V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260009134 | 260005974 | 1.65 | null | Palliative (P) | 2018-03-05 | 2018-03-18 | Rituximab | 2 | N | 260029273 | RITUXIMAB |
| 260009135 | 260005974 | 1.73 | 80.2 | Disease modification (D) | 2017-01-15 | 2017-01-16 | Rituximab | N | N | 260029273 | CHLVPP |
| 260009136 | 260017428 | null | null | Disease modification (D) | 2018-04-03 | 2018-04-03 | GALLIUM TRIAL | 02 | N | 260029280 | CISPLATIN + RT |
| 260009137 | 260005975 | null | 70 | null | null | 2018-01-20 | Rituximab (Maintenance) | null | null | 260029288 | PACIFICO TRIAL |
| 260009138 | 260005975 | null | 96 | Adjuvant (A) | 2017-09-06 | 2017-10-09 | Capecitabine + Cisplatin | N | N | 260029288 | ABVD |
| 260009139 | 260005975 | null | null | Curative (C) | 2016-05-08 | 2016-05-12 | Trial Unspecified | N | N | 260029288 | VINCRISTINE |
| 260009140 | 260005976 | 1.64 | 101 | Disease modification (D) | 2016-10-08 | 2016-10-21 | Rituximab | N | N | 260029293 | RITUXIMAB |
| 260009141 | 260005977 | 1.8 | 75 | Disease modification (D) | 2016-11-02 | 2016-11-09 | Obinutuzumab + CHOP | 2 | N | 260029296 | RITUXIMAB |
| 260009142 | 260005977 | null | 60 | Palliative (P) | null | 2016-06-08 | Bendamustine + prednisolone | null | null | 260029296 | RITUXIMAB |
| 260009143 | 260005978 | 1.57 | 45.1 | null | null | 2015-06-14 | CVP | null | null | 260029298 | RITUXIMAB |
| 260009144 | 260005978 | 1.8 | 79.4 | Not known (9) | 2015-11-26 | 2015-12-17 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | N | N | 260029298 | BENDAMUSTINE |
| 260009145 | 260005979 | 1.6 | 61.8 | Disease modification (D) | 2014-06-26 | 2014-06-27 | CHOP - 21 days | 01 | N | 260029302 | RITUXIMAB |
| 260009146 | 260005979 | 1.78 | 75.9 | Palliative (P) | 2015-06-08 | 2015-06-23 | Rituximab | N | N | 260029302 | RITUXIMAB |
| 260009147 | 260005979 | 1.69 | 105.2 | Curative (C) | 2015-02-07 | 2015-02-20 | Rituximab | 02 | N | 260029302 | RITUXIMAB |
| 260009148 | 260005980 | 1.74 | 76.4 | Not known (9) | 2018-10-08 | 2018-10-08 | null | 02 | N | 260029305 | RITUXIMAB |
| 260009149 | 260012164 | 1.52 | 62.2 | Palliative (P) | 2015-04-10 | 2015-04-11 | FLUOROURACIL + MITOMYCIN + RT | 02 | N | 260029310 | RITUXIMAB |
| 260009150 | 260005981 | 1.69 | 0 | Disease modification (D) | 2016-12-13 | 2016-12-13 | RCEOP | 2 | N | 260029311 | ESHAP |
| 260009151 | 260005981 | null | null | Adjuvant (A) | 2017-02-23 | 2017-03-11 | Rituximab | N | N | 260029311 | RITUXIMAB |
| 260009152 | 260005982 | 1.76 | null | Palliative (P) | 2018-05-13 | 2018-05-25 | null | N | N | 260029314 | FCR |
| 260009153 | 260012166 | 0 | 119.2 | Curative (C) | 2013-10-23 | 2013-11-17 | Rituximab (Maintenance) | N | 2 | 260029315 | CYCLO + RITUXIMAB + VINCRISTINE |
| 260009154 | 260012166 | 1.71 | 81 | Palliative (P) | 2013-10-09 | 2013-10-16 | Rituximab | N | N | 260029315 | RITUXIMAB |
| 260009155 | 260005983 | 1.65 | null | Curative (C) | 2016-07-29 | 2016-08-23 | Rituximab | N | N | 260029318 | CARBOPLATIN + PACLITAXEL |
| 260009156 | 260005983 | null | 94.2 | Curative (C) | 2016-07-01 | 2016-11-11 | Rituximab | 2 | N | 260029318 | GEMCITABINE + OXALIPLATIN + RITUXIMAB |
| 260009157 | 260005984 | 1.78 | null | null | 2016-06-30 | 2016-08-09 | Rituximab (Maintenance) | N | N | 260029321 | BENDAMUSTINE |
| 260009158 | 260005984 | 1.65 | 121 | Disease modification (D) | 2017-12-08 | 2017-12-10 | Bendamustine +/- Prednisolone | 2 | N | 260029321 | RITUXIMAB |
| 260009159 | 260005985 | 1.85 | null | Palliative (P) | 2016-12-13 | 2016-12-13 | EP 1 2 or 3 day | 2 | N | 260029326 | CARBOPLATIN + ETOPOSIDE |
| 260009160 | 260005986 | 1.83 | null | Curative (C) | 2014-08-20 | 2014-08-21 | Rituximab | 02 | N | 260029328 | GEFITINIB |
| 260009161 | 260012169 | 1.57 | 60.1 | Palliative (P) | 2018-05-07 | 2018-05-15 | PACIFICO TRIAL | 01 | Y | 260029330 | RITUXIMAB |
| 260009162 | 260012169 | 1.64 | 79.9 | null | null | 2014-10-25 | Carboplatin + Pemetrexed | null | null | 260029330 | CISPLATIN + ETOPOSIDE |
| 260009163 | 260012169 | 1.74 | 76 | Adjuvant (A) | 2015-04-23 | 2015-05-02 | Rituximab | N | N | 260029330 | RITUXIMAB |
| 260009164 | 260005987 | 1.79 | null | null | 2017-07-26 | 2017-07-26 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | N | N | 260029335 | CISPLATIN + ETOPOSIDE |
| 260009165 | 260005987 | 0 | 77.7 | null | 2014-03-22 | 2014-03-26 | ESHAP | 02 | Y | 260029335 | NOT MATCHED |
| 260009166 | 260005988 | 1.82 | 82.9 | Curative (C) | 2015-09-27 | 2015-10-09 | ESHAP | N | N | 260029339 | RITUXIMAB |
| 260009167 | 260005988 | null | null | Not known (9) | 2014-06-26 | 2014-07-29 | PACIFICO TRIAL | N | N | 260029339 | RITUXIMAB |
| 260009168 | 260005989 | 1.69 | 129.7 | Palliative (P) | 2013-10-24 | 2013-11-27 | RCEOP | N | N | 260029346 | RITUXIMAB |
| 260009169 | 260012172 | 1.91 | 79 | Palliative (P) | null | 2013-04-09 | CHOP - 21 days | N | N | 260029347 | PACIFICO TRIAL |
| 260009170 | 260005990 | 1.45 | null | Curative (C) | 2013-09-11 | 2013-10-12 | Bendamustine + prednisolone | N | Y | 260029348 | RITUXIMAB |
| 260009171 | 260005990 | 1.64 | 78.4 | Curative (C) | 2014-06-13 | 2014-07-06 | Rituximab | 02 | N | 260029348 | RITUXIMAB |
| 260009172 | 260005990 | 1.72 | 94 | Palliative (P) | null | 2013-12-23 | Carboplatin + Etoposide IV 3 day | N | N | 260029348 | RCEOP |
| 260009173 | 260005991 | 1.84 | 85 | Disease modification (D) | 2014-04-04 | 2014-04-26 | PACIFICO TRIAL | N | N | 260029355 | RITUXIMAB |
| 260009174 | 260005991 | 1.88 | 63.8 | Disease modification (D) | 2016-09-05 | 2016-09-12 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | 02 | N | 260029355 | CISPLATIN + ETOPOSIDE |
| 260009175 | 260005991 | 1.83 | 137 | Palliative (P) | 2017-03-17 | 2017-03-21 | Rituximab | N | N | 260029355 | GEMCARBO |
| 260009176 | 260005992 | 1.68 | 70.7 | Curative (C) | 2014-08-08 | 2014-08-08 | Rituximab | N | 2 | 260029360 | IRINOTECAN + MDG |
| 260009177 | 260005993 | null | 105.8 | Curative (C) | 2014-11-04 | 2014-11-04 | Rituximab (SUBCUTANEOUS Maintenance) | N | null | 260029361 | RITUXIMAB |
| 260009178 | 260005993 | null | 58.2 | Curative (C) | 2016-07-11 | 2016-07-20 | BEAM | N | N | 260029361 | BENDAMUSTINE |
| 260009179 | 260005993 | 1.62 | 73.6 | Curative (C) | 2016-07-17 | 2016-07-24 | CHOP - 21 days | N | N | 260029361 | RITUXIMAB |
| 260009180 | 260005993 | 1.8 | 90 | Palliative (P) | 2013-07-09 | 2013-07-30 | Rituximab | N | N | 260029361 | RITUXIMAB |
| 260009181 | 260005994 | 1.78 | 89.9 | Curative (C) | 2018-12-26 | 2019-01-01 | Rituximab | N | N | 260029368 | NOT MATCHED |
| 260009182 | 260005994 | null | 79.8 | Palliative (P) | 2016-01-19 | 2016-01-23 | Rituximab (Maintenance) | 02 | N | 260029368 | FLUOROURACIL |
| 260009183 | 260005995 | null | null | Disease modification (D) | 2017-11-07 | 2017-11-21 | Rituximab | N | N | 260029371 | RITUXIMAB |